<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004808'>Acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) patients (24 consecutive patients, median age 71 years, 17 high-risk disease) were treated with <z:hpo ids='HP_0000001'>all</z:hpo>-trans <z:chebi fb="2" ids="26536">retinoic acid</z:chebi>, <z:chebi fb="1" ids="28177">theophylline</z:chebi> and <z:chebi fb="0" ids="39867">valproic acid</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Among 22 evaluable patients 9 responded with increased <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood cell counts </plain></SENT>
<SENT sid="2" pm="."><plain>The responses could be classified as hematological improvement according to response criteria for patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) for four patients only </plain></SENT>
<SENT sid="3" pm="."><plain>The nine patients with increased <z:mpath ids='MPATH_458'>normal</z:mpath> cell counts had a median survival from start of therapy of 147 days compared with 48 days for the other patients </plain></SENT>
<SENT sid="4" pm="."><plain>Four patients fulfilling the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> criteria had a survival ranging from 112 to 644 days </plain></SENT>
<SENT sid="5" pm="."><plain>The treatment was associated with decreased in vitro cytokine-dependent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cell proliferation and increased blood levels of Endocan and angiopoietin-2 both for responders and non-responders </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that the therapy causes disease stabilization for a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients </plain></SENT>
</text></document>